The clinical relevance of sexual dysfunction in systemic sclerosis

Autoimmunity Reviews

Volumn 14, Issue 12, 2015, Pages 1111-1115

  Bruni, C ^a   Raja, J ^b,c   Denton, C P ^c   Matucci Cerinic, M ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Erectile dysfunction; Sexual dysfunction; Systemic sclerosis

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR;

ERECTILE DYSFUNCTION; FEMALE SEXUAL DYSFUNCTION; HUMAN; MEDICAL DEVICE; REVIEW; SEXUAL DYSFUNCTION; SYSTEMIC SCLEROSIS; VACUUM CONSTRICTION DEVICE; ANIMAL; CHRONIC DISEASE; COMPLICATION; PREVALENCE; QUALITY OF LIFE; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

ANIMALS; CHRONIC DISEASE; HUMANS; PREVALENCE; QUALITY OF LIFE; SCLERODERMA, SYSTEMIC; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 84945473203     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2015.07.016     Document Type: Review

References (62)

1. Van Den Hoogen F., Khanna D., Frensen J., et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013, 65(11):2737-2747.
2. Malcarne V.L., Fox R.S., Mills S.D., Gholizadeh S. Psychosocial aspects of systemic sclerosis. Curr Opin Rheumatol 2013, 25(6):707-713.
3. Knafo R., Thombs B.D., Jewett L., et al. (Not) talking about sex: a systematic comparison of sexual impairment in women with systemic sclerosis and other chronic disease samples. Rheumatology (Oxford) 2009, 48(10):1300-1303.
4. Grant P., Jackson G., Baig I., et al. Erectile dysfunction in general medicine. Clin Med 2013, 13(2):136-140.
5. Ritchie R., Sullivan M. Endothelins & erectile dysfunction. Pharmacol Res 2011, 63(6):496-501.
6. Thompson I.M., Tangen C.M., Goodman P.J., Probstfield J.L., Moinpour C.M., Coltman C.A. Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005, 294(23):2996-3002.
7. Seftel A.D. Diagnosis of erectile dysfunction. Standard practice in sexual medicine 2006, Blackwell Publishing, Oxford. H. Prost, J. Buvat (Eds.).
8. British society for sexual medicine guidelines on the management of erectile dysfunction, developed by British Society for Sexual Medicine, 2009.
9. Hatzichristou D.G., Hatzimouratidis K., Ioannides E., Yannakoyorgos K., Dimitriadis G., Kalinderis A. Nocturnal penile tumescence and rigidity monitoring in young potent volunteers: reproducibility, evaluation criteria and the effect of sexual intercourse. J Urol 1998, 159(6):1921-1926.
10. Meuleman E.J., Diemont W.L. Investigation of erectile dysfunction. Diagnostic testing for vascular factors in erectile dysfunction. Urol Clin North Am 1995, 22(4):803-819. (Review).
11. Rosen R.C., Riley A., Wagner G., et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997, 49(6):822-830.
12. Ponholzer A., Temml C., Mock K., et al. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol 2005, 47(1):80-85. (discussion 85-6).
13. Lally E.V., Jimenez S.A. Erectile failure in systemic sclerosis. N Engl J Med 1990, 322(19):1398-1399.
14. Sukenik S., Horowitz J., Buskila D., et al. Impotence in systemic sclerosis. Ann Intern Med 1987, 106(6):910-911.
15. Sukenik S., Abarbanel J.M., Buskila D., et al. Impotence, carpal tunnel syndrome and peripheral neuropathy as presenting symptoms in progressive systemic sclerosis. J Rheumatol 1987, 14(3):641-643.
16. Nowlin N.S., Brick J.E., Weaver D.J., et al. Impotence in scleroderma. Ann Intern Med 1986, 104(6):794-798.
17. Lotfi M.A., Varga J., Hirsch I.H. Erectile dysfunction in systemic sclerosis. Urology 1995, 45(5):879-881.
18. Hong P., Pope J.E., Ouimet J.M., et al. Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis. J Rheumatol 2004, 31(3):508-513.
19. Foocharoen C., Tyndall A., Hachulla E., et al. Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group. Arthritis Res Ther 2012, 14(1):R37.
20. Walker U.A., Tyndall A., Ruszat R. Erectile dysfunction in systemic sclerosis. Ann Rheum Dis 2009, 68(7):1083-1085.
21. Impens A.J., Seibold J.R. Vascular alterations and sexual function in systemic sclerosis. Int J Rheumatol 2010, 2010:139020.
22. Ostojic P., Damjanov N. The impact of depression, microvasculopathy, and fibrosis on development of erectile dysfunction in men with systemic sclerosis. Clin Rheumatol 2007, 26(10):1671-1674. (Epub 2007 Feb 10).
23. Nehra A., Hall S.J., Basile G., et al. Systemic sclerosis and impotence: a clinicopathological correlation. J Urol 1995, 153(4):1140-1146.
24. Aversa A., Bruzziches R., Francomano D., et al. Penile involvement in systemic sclerosis: new diagnostic and therapeutic aspects. Int J Rheumatol 2010, 2010:708067.
25. Varga J., Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007, 117(3):557-567. (Review).
26. Keck A.D., Foocharoen C., Rosato E., et al. Nailfold capillary abnormalities in erectile dysfunction of systemic sclerosis: a EUSTAR group analysis. Rheumatology (Oxford) 2014, 53(4):639-643.
27. Aversa A., Proietti M., Bruzziches R., et al. The penile vasculature in systemic sclerosis: a duplex ultrasound study. J Sex Med 2006, 3(3):554-558.
28. Rosato E., Aversa A., Molinaro I., Pisarri S., Spera G., Salsano F. Erectile dysfunction of sclerodermic patients correlates with digital vascular damage. Eur J Intern Med 2011, 22(3):318-321.
29. Rosato E., Barbano B., Gigante A., et al. Erectile dysfunction, endothelium dysfunction, and microvascular damage in patients with systemic sclerosis. J Sex Med 2013, 10(5):1380-1388.
30. Rosato E., Barbano B., Gigante A., et al. Doppler ultrasound study of penis in men with systemic sclerosis: a correlation with Doppler indices of renal and digital arteries. Int J Immunopathol Pharmacol 2013, 26(4):1007-1011.
31. Merla A., Romani G.L., Tangherlini A, et al. Penile cutaneous temperature in systemic sclerosis: a thermal imaging study. Int J Immunopathol Pharmacol 2007, 20(1):139-144.
32. Gupta B.P., Murad M.H., Clifton M.M., et al. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med 2011, 171(20):1797-1803.
33. Smith W.B., McCaslin I.R., Gokce A., et al. PDE5 inhibitors: considerations for preference and long-term adherence. Int J Clin Pract 2013, 67(8):768-780.
34. Bruzziches R., Francomano D., Gareri P., et al. An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors. Expert Opin Pharmacother 2013, 14(10):1333-1344.
35. Aversa A., Greco E., Bruzziches R., et al. Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study. Int J Impot Res 2007, 19(2):200-207.
36. Proietti M., Aversa A., Letizia C., et al. Erectile dysfunction in systemic sclerosis: effects of longterm inhibition of phosphodiesterase type-5 on erectile function and plasma endothelin-1 levels. J Rheumatol 2007, 34(8):1712-1717.
37. Li P., Shen Y.J., Liu T.Q., et al. Vacuum therapy for erectile dysfunction that fails to respond to PDE-5i: report of 70 cases. Zhonghua Nan Ke Xue 2013, 19(3):236-240.
38. McMahon C.G. Erectile dysfunction. Intern Med J 2014, 44(1):18-26.
39. Hanchanale V., Eardley I. Alprostadil for the treatment of impotence. Expert Opin Pharmacother 2014, 15(3):421-428.
40. Pavone C., Napoli G., Caruana G., et al. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study. BJU Int 2012, 110(1):117-121.
41. Trost L.W., McCaslin R., Linder B., et al. Long-term outcomes of penile prostheses for the treatment of erectile dysfunction. Expert Rev Med Devices 2013, 10(3):353-366.
42. Condorelli R.A., Calogero A.E., Vicari E., et al. Vascular regenerative therapies for the treatment of erectile dysfunction: current approaches. Andrology 2013, 1(4):533-540.
43. Berman J.R., Adhikari S.P., Goldstein I. Anatomy and physiology of female sexual function and dysfunction. Eur Urol 2000, 38:20-29.
44. Basson R., Berman J., Burnett A., et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000, 163(3):888-893.
45. Schouffoer A.A., van der Marel J., Ter Kuile M.M., Weijenborg P.T., Voskuyl A., Vliet Vlieland C.W., et al. Impaired sexual function in women with systemic sclerosis: a cross-sectional study. Arthritis Rheum 2009, 61(11):1601-1608.
46. Impens A.J., Rothman J., Schiopu E., Cole J.C., Dang J., Gendrano N., et al. Sexual activity and functioning in female scleroderma patients. Clin Exp Rheumatol 2009, 27(3 Suppl. 54):38-43.
47. Bhadauria S., Moser D.K., Clements P.J., Singh R.R., Lachenbruch P.A., Pitkin R.M., et al. Genital tract abnormalities and female sexual function impairment in systemic sclerosis. Am J Obstet Gynecol 1995, 172(2 Pt 1):580-587.
48. Knafo R., Haythornthwaite J.A., Heinberg L., Wigley F.M., Thombs B.D. The association of body image dissatisfaction and pain with reduced sexual function in women with systemic sclerosis. Rheumatology (Oxford) 2011, 50(6):1125-1130.
49. Rosen R., Brown C., Heiman J., Leiblum S., Meston C., Shabsigh R., et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000, 26(2):191-208.
50. Lutfey K.E., Link C.L., Rosen R.C., Wiegel M., McKinlay J.B. Prevalence and correlates of sexual activity and function in women: results from the Boston Area Community Health (BACH) Survey. Arch Sex Behav 2009, 38(4):514-527.
51. Maddali Bongi S., Del Rosso A., Mikhaylova S., Baccini M., Matucci Cerinic M. Sexual function in Italian women with systemic sclerosis is affected by disease-related and psychological concerns. J Rheumatol 2013, 40(10):1697-1705.
52. Jewett L.R., Hudson M., Haythornthwaite J.A., Heinberg L., Wigley F.M., Baron M., et al. Development and validation of the brief-satisfaction with appearance scale for systemic sclerosis. Arthritis Care Res 2010, 62(12):1779-1786.
53. Levis B., Burri A., Hudson M., Baron M., Thombs B.D., Canadian Scleroderma Research Group (CSRG) Sexual activity and impairment in women with systemic sclerosis compared to women from a general population sample. PLoS One 2012, 7(12):e52129.
54. Levis B., Hudson M., Knafo R., Baron M., Nielson W.R., Hill M., et al. Rates and correlates of sexual activity and impairment among women with systemic sclerosis. Arthritis Care Res 2012, 64(3):340-350.
55. Rosato E., Gigante A., Barbano B., La Marra F., Molinaro I., Quarta S., et al. Clitoral blood flow in systemic sclerosis women: correlation with disease clinical variables and female sexual dysfunction. Rheumatology (Oxford) 2013, 52(12):2238-2242.
56. Chivers M.L., Rosen R.C. Phosphodiesterase type 5 inhibitors and female sexual response: faulty protocols or paradigms?. J Sex Med 2010, 7(2):858-872.
57. Caruso S., Rugolo S., Agnello C., Intelisano G., Di Mari L., Cianci A. Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder: a double-blind, crossover, placebo-controlled pilot study. Fertil Steril 2006, 85(5):1496-1501.
58. Caruso S., Intelisano G., Lupo L., Agnello C. Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study. BJOG 2001, 108(6):623-628.
59. Schiopu E., Hsu V.M., Impens A.J., et al. Randomized placebo-controlled crossover trial of tadalafil in Raynaud's phenomenon secondary to systemic sclerosis. J Rheumatol 2009, 36(10):2264-2268.
60. Saad S.C., Behrendt A.E. Scleroderma and sexuality. J Sex Res 1996, 33:215-220.
61. Saad S.C., Pietrzykowski J.E., Lewis S.S., et al. Vaginal lubrication in women with scleroderma and Sjogren's syndrome. Sex Disabil 1999, 17:103-113.
62. Ambler N., Williams A.C.D.C., Hill P., Gunary R., Cratchley G. Sexual difficulties of chronic pain patients. Clin J Pain 2001, 17:138-145.